Crossmark

The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT‐TCF pathway responses in human cancer

Published Online: 2014-08-20

Published Print: 2014-10-01

Authors

Melotti, Alice

Mas, Christophe

Kuciak, Monika

Lorente‐Trigos, Aiala

Borges, Isabel

Ruiz i Altaba, Ariel
Funding

Funding for this research was provided by:

Swiss Cancer League

Swiss National Science Foundation

European Union Programs

USA James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer—Research Award

Département d'Instruction Publique de la République et Canton of Genève
License Information

Text and Data Mining valid from 2014-08-20

Version of Record valid from 2014-08-20
More Information

Article History

Received: 18 March 2014

Revised: 14 July 2014

Accepted: 15 July 2014

First Online: 20 August 2014

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current